1-3 of 3
Parvathi Ranganathan
Close
Sort by
Journal Articles

CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model

Lotus Neidemire-Colley, Shrijan Khanal, Kara M. Braunreiter, Yandi Gao, Rathan Kumar, Katiri J. Snyder, Margot A. Weber, Simran Surana, Olimjon Toirov, Malith Karunasiri, Molly E. Duszynski, Mengna Chi, Punam Malik, Sonu Kalyan, Wing K. Chan, Meisam Naeimi Kararoudi, Hannah K. Choe, Ramiro Garzon, Parvathi Ranganathan
Journal: Blood Advances
Blood Adv (2024) 8 (4): 947–958.
https://doi.org/10.1182/bloodadvances.2023010570
Published: 2024
Includes: Supplemental data
Journal Articles

Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice

Adrienne M. Dorrance, Moutuaata M. Moutuou, Chinmayee Goda, Natalie E. Sell, Sonu Kalyan, Malith Karunasiri, Rohan Kulkarni, Marie Goulard, Sofia Kolovich, Alexander Rudich, Eric Naumann, Antoine Ackaoui, Charles-Etienne Bigras, Francis Daudelin, Ramiro Garzon, Parvathi Ranganathan, Martin Guimond
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2403–2408.
https://doi.org/10.1182/bloodadvances.2021005498
Published: 2022
Includes: Supplemental data
Journal Articles

Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD

Clinical Trials & Observations
Sarah A. Wall, Qiuhong Zhao, Martha Yearsley, Luke Blower, Akwasi Agyeman, Parvathi Ranganathan, Shangbin Yang, Haiwa Wu, Matthew Bostic, Samantha Jaglowski, Jonathan E. Brammer, Basem William, Hannah Choe, Alice S. Mims, Sam Penza, Yvonne Efebera, Steven Devine, Spero Cataland, Stella M. Davies, Sumithira Vasu
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2619–2628.
https://doi.org/10.1182/bloodadvances.2018020321
Published: 2018
Includes: Supplemental data